Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Tweaked COVID boosters close but how much will they help?

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but how much will they help

The Independent UK

How common is Paxlovid rebound as Jill Biden tests positive again for Covid?

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

The Independent UK

Study: Pfizer COVID pill showed no benefit in younger adults

Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

How common is Paxlovid rebound as Jill Biden tests positive again for Covid?

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

The Independent UK

A looming COVID risk in California? Schools return with fewer rules, lagging vaccine rates

LOS ANGELES — California schools reopened for the fall semester with loosened COVID-19 protocols and low student vaccination rates among younger children, presenting a new test for the trajectory of the pandemic as some experts expect another rise in cases when winter arrives.

Los Angeles Times

Pfizer COVID shots appear 73% effective in children under 5

Pfizer’s says its COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring

The Independent UK

What Are Whales Doing With Pfizer

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 10 strange trades.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Pfizer’s shot is 73% effective against COVID in children under 5

Pfizer Inc.’s COVID-19 vaccine was 73.2% effective against the disease in a trial of children 6 months through 4 years old, reinforcing results that led to the shot’s authorization in young kids in June.

Tribune News Service

Pfizer files application for booster against latest variants

Pfizer Inc. and BioNTech SE asked the U.S. to authorize a new COVID-19 booster shot customized against the currently circulating COVID-19 variants as governments race to protect their populations against the ever-mutating virus.

Tribune News Service

Pfizer asks FDA to greenlight new omicron booster shots, which could arrive this fall

Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.

WEKU

Pfizer seeks OK of updated COVID vaccine booster for fall

Pfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives

The Independent UK

Next phase of Covid jabs rollout starts next month

Around 26m people across England eligible for autumn booster

Wales Online

Covid vaccine plan for the very young

The government plans to buy 2.9 million doses of Covid-19 vaccine from Pfizer for children aged from six months to four years.

Bangkok Post

Covid booster rollout of dual-strain jab to start on 5 September

Moderna’s new dual-strain vaccine will be offered to millions of Britons ahead of winter

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

What's behind the FDA's controversial strategy for evaluating new COVID boosters

Some scientists are alarmed that the agency plans to evaluate the next generation of boosters by reviewing mouse studies alone. Others say there's no time to waste waiting for human trials.

Daily Mirror

All over-50s to get a new Covid jab targeted to protect against Omicron variant

Britain became the first country to approve a “bivalent” jab on Monday that directly targets Omicron and the original Covid-19 strain - as 29 million people will initially be invited for the vaccine

The Independent UK

‘No second-rate vaccines’ health chief insists as half will miss out on dual-strain booster

Roughly 29 million people are eligible for an autumn booster but there are just 13 million doses of the new bivalent Moderna jab available

StockNews.com

5 Income Stocks to Turn to When Times Are Tough

The S&P 500 is coming off its four-week win streak amid signals of cooling price increases. However, inflation is still running hot near a 40-year high, which might induce the Fed to continue its policy rate hikes. We think income stocks AbbVie (ABBV), Amgen (AMGN), Pfizer (PFE), Bristol-Myers Squibb (BMY),…

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

No plans for UK to order more supplies of AstraZeneca Covid vaccine

JCVI says mRNA vaccines such as the Pfizer and Moderna jabs are the most effective for UK booster programme

Wales Online

What we know so far about the autumn booster roll-out

It's not known how long the vaccines will offer protection for, experts have admitted

WEKU

The U.K. approved omicron-specific booster shots. They're coming to the U.S. soon

In the U.S., officials have asked vaccine makers to target BA.5, rather than the original omicron strain. That has delayed the boosters' development — but officials hope they will be more effective.

The Independent UK

Government ‘confident’ people will get ‘bivalent’ jab in booster programme

The comments come after it emerged that current stock would cover only half the population eligible for the booster jab.

Wales Online

Who is eligible to get a Covid booster jab this autumn

Some people will be offered a Moderna jab and others the Pfizer vaccine

The Independent UK

Pfizer CEO tests positive for Covid

Albert Bourla has already received four doses of the Pfizer-BioNTech vaccine

The Independent UK

Pfizer CEO tests positive for COVID-19, has mild symptoms

The top executive at Pfizer, a leading producer of COVID-19 vaccines, has tested positive for the virus and says he is experiencing very mild symptoms

1 … 41 42 43 44

People

Taweesilp Visanuyothin

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

BristolMyers Squibb Company

95 stories

BioNTech SE

82 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.